Investor Presentaiton slide image

Investor Presentaiton

Guardant today $548M 160+ 2023 Revenue Guidance Midpoint¹ 60+ Biopharma Partners Countries GUARDANT™ 1 FY 2023 Revenue guidance of $545 - $550M updated August 3, 2023 INVESTOR 20 DAY 23 600+ Global Patents & Patent Applications 17
View entire presentation